Loading
Latest filing published 11 Jul 2022 for Entasis Therapeutics Holdings Inc., €86k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Ruben Tommasi in Entasis Therapeutics Holdings Inc., where the filings describe the role as board member. Over a trading history stretching from 19 October 2021 to 7 July 2022, the count stands at 3 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 11 July 2022 with a transaction (€86k) in Entasis Therapeutics Holdings Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations